Skip to main content

Centiva Capital, LP

Position in OCUL — Ocular Therapeutix, Inc

CIK 1692507 New York, NY

Position in OCUL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$216,275
+$4,525 QoQ
Shares Held
22,024
-11.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#165
of 257 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Derivatives in OCUL

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$245,500
PutShares
25,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Centiva Capital, LP holds $32,694,585 across 26 Biotechnology names. OCUL ranks #17 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCUL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $245,500 25,000
2026-06-30 $216,275 22,024
2026-03-31 $211,750 25,000
2026-03-31 $301,532 35,600
2026-03-31 $211,750 25,000
2025-12-31 $4,636,266 381,900
2025-09-30 $267,701 22,900
2025-09-30 $2,922,500 250,000
2024-03-31 $564,691 62,054